Precision Genomics

Project exhibits severe red flags and contradictions. The claim that 'most people have used my product' is entirely unsubstantiated and directly contradicts the reported $2.5M market cap and lack of active user data. Responses are highly hyperbolic, utilizing buzzwords like 'never-before-seen' mRNA and deep learning technology, yet fail to provide concrete evidence, realistic metrics, or credible technical documentation. A negative score is assigned in strict alignment with calibration guidelines for deceptive or unverifiable traction.